Clinical Trial: NRG CCTG-BR38

NRG CCTG-BR38

Status: Open

Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression in Patients with Metastatic Non-Small-Cell Lung Cancer – A Randomized Phase 3 Trial

Eligible for screening study DCP 001

 Completion of Pre-Registration QOLs is required after consent, prior to registration. Please see study documents.